ARID2: A new tumor suppressor gene in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, however, genetic-environmental interactions and mechanisms associated with the development of HCC remains largely unclear. Our recent work described novel inactivating mutations of ARID2 (AT-rich interactive domain 2) i...
Main Authors: | Zhao, Hong, Wang, Jian, Han, Yongqing, Huang, Zhen, Ying, Jianming, Bi, Xinyu, Zhao, Jianjun, Fang, Yi, Zhou, Haitao, Zhou, Jianguo, Li, Zhiyu, Zhang, Yefan, Yang, Xue, Yan, Tao, Wang, Linfang, Torbenson, Michael S., Cai, Jianqiang |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259997/ |
Similar Items
-
Prognosis of patients with hepatocellular carcinoma and hypersplenism after surgery: a single-center experience from the People’s Republic of China
by: Li, Cong, et al.
Published: (2014) -
Recent advances in the ARID family: focusing on roles in human cancer
by: Lin, Chen, et al.
Published: (2014) -
Simultaneous hepatic resection benefits patients with synchronous colorectal cancer liver metastases
by: Li, Yuan, et al.
Published: (2016) -
Variants Identified by Hepatocellular Carcinoma and Chronic Hepatitis B Virus Infection Susceptibility GWAS Associated with Survival in HBV-Related Hepatocellular Carcinoma
by: Li, Cong, et al.
Published: (2014) -
CEA Level, Radical Surgery, CD56 and CgA Expression Are Prognostic Factors for Patients With Locoregional Gastrin-Independent GNET
by: Li, Yuan, et al.
Published: (2016)